NeuroPace NPCE Institutional Ownership

Updated Oct 10, 2026

NeuroPace Inc (NASDAQ:NPCE) was reported as a holding by 113 institutional investors in 13F filings for the quarter ended June 30, 2026.

• Collectively, these holders controlled 77.53% of NeuroPace's outstanding shares in Q2 2026, down from 78.03% in Q1 2026.
• Total holdings of NeuroPace shares rose 0.46% from Q1 2026, and the number of holders rose 17.71% from Q2 2025.
• Of the 113 holders, 66 added to their positions, 37 reduced their stakes and 10 left their positions unchanged in Q2 2026.
• Altogether, institutional holders owned 26.58Mn NPCE shares at the end of Q2 2026, up 122.72K from the prior quarter and up 6.66Mn from a year earlier.
• Polar Capital Holdings PLC was the top holder of NeuroPace as of June 30, 2026, with 3.3Mn shares, or 9.62% of shares outstanding.
• The largest position increases in NPCE for Q2 2026 were by First Light Asset Management, LLC (+401.2K shares), BlackRock, Inc. (+131.27K shares), D. E. Shaw & Co., Inc. (+117.46K shares), Vanguard Capital Management LLC (+103.36K shares) and HighMark Wealth Management LLC (+100K shares).
• The largest position reductions in NPCE for Q2 2026 were by OrbiMed Advisors LLC (-591.4K shares), Renaissance Technologies LLC (-62.61K shares), SEI Investments Co (-59.3K shares), Two Sigma Investments, LP (-43.9K shares) and Connor, Clark & Lunn Investment Management Ltd. (-28.14K shares).
• According to Business Quant data, the leading holders of NPCE for Q2 2026 were Polar Capital Holdings PLC (3.3Mn shares), Soleus Capital Management, L.P. (2.91Mn shares), First Light Asset Management, LLC (2.86Mn shares), Morgan Stanley (2.65Mn shares), BlackRock, Inc. (2.48Mn shares), OrbiMed Advisors LLC (1.51Mn shares), Driehaus Capital Management LLC (1.45Mn shares), Vanguard Capital Management LLC (1.23Mn shares), Deutsche Bank AG (938.92K shares) and Armistice Capital, LLC (692K shares).